



• Stability testing of pharmaceutical products is a complex set of 
procedures involving considerable cost, time consumption and 
scientific expertise in order to build in quality, efficacy and 
safety in a drug formulation.  
• Scientific and commercial success of a pharmaceutical product 
can only be ensured with the understanding of the drug 
development process and the myriad tasks and milestones that 
are vital to a comprehensive development plan.  
• The most important steps during the developmental stages 
include pharmaceutical analysis and stability studies that are 
required to determine and assure the identity, potency and 
purity of ingredients, as well as those of the formulated 
products 
INTRODUCTION 
• Stability of a pharmaceutical product may be defined as the 
capability of a particular formulation in a specific container/closure 
system to remain within its physical, chemical, microbiological, 
toxicological, protective and informational specifications 
• In other words, it is the extent to which a product retains, within the 
specified limits, throughout its period of storage and use, the same 
properties and characteristics possessed at the time of its packaging.  
• Stability testing thus evaluates the effect of environmental factors on 
the quality of the a drug substance or a formulated product which is 
utilized for prediction of its shelf life, determine proper storage 
conditions and suggest labeling instructions.  
• The data generated during the stability testing is an important 
requirement for regulatory approval of any drug or formulation 
INTRODUCTION 
• Stability testing is termed as a complex process because of 
involvement of a variety of factors influencing the stability of 
a pharmaceutical product.  
• These factors include stability of the active ingredient(s); 
interaction between active ingredients and excipients, 
manufacturing process followed, type of dosage form, 
container/closure system used for packaging and light, heat 
and moisture conditions encountered during shipment, storage 
and handling 
• In addition, degradation reactions like oxidation, reduction, 
hydrolysis or racemization, which can play vital role in 
stability of a pharmaceutical product, also depend on such 
conditions like concentration of reactants, pH, radiation, 
catalysts etc., as well as the raw materials used and the length 
of time between manufacture and usage of the product. 
INTRODUCTION 
• A pharmaceutical product may undergo change in appearance, 
consistency, content uniformity, clarity (solution), moisture contents, 
particle size and shape, pH, package integrity thereby affecting its 
stability.  
• Such physical changes may be because of impact, vibration, abrasion, 
and temperature fluctuations such as freezing, thawing or shearing 
etc.  
• The chemical reactions like solvolysis, oxidation, reduction, 
racemization etc. that occur in the pharmaceutical products may lead 
to the formation of degradation product, loss of potency of active 
pharmaceutical ingredient (API), loss of excipient activity like 
antimicrobial preservative action and antioxidants etc. 
• Stability of a pharmaceutical product can also be affected because of 
microbiological changes like growth of microorganisms in non sterile 
products and changes in preservative efficacy 
STABILITY TESTING 
METHODS 
• Stability testing is a routine procedure performed on drug 
substances and products and is employed at various stages of 
the product development.  
• In early stages, accelerated stability testing (at relatively high 
temperatures and/or humidity) is used in order to determine the 
type of degradation products which may be found after long-
term storage. Testing under less rigorous conditions i.e. those 
recommended for long-term shelf storage, at slightly elevated 
temperatures is used to determine a product’s shelf life and 
expiration dates.  
• The major aim of pharmaceutical stability testing is to provide 
reasonable assurance that the products will remain at an 
acceptable level of fitness/quality throughout the period during 
which they are in market place available for supply to the 
patients and will be fit for their consumption until the patient 
uses the last unit of the product 
STABILITY TESTING 
METHODS 
REAL TIME STABILITY TESTING 
• Real-time stability testing is normally performed for longer duration of 
the test period in order to allow significant product degradation under 
recommended storage conditions.  
• The period of the test depends upon the stability of the product which 
should be long enough to indicate clearly that no measurable degradation 
occurs and must permit one to distinguish degradation from inter-assay 
variation 
• During the testing, data is collected at an appropriate frequency such that 
a trend analysis is able to distinguish instability from day-to-day 
ambiguity.  
• The reliability of data interpretation can be increased by including a 
single batch of reference material for which stability characteristics have 
already been established.  
• Stability of the reference material also includes the stability of reagents 
as well as consistency of the performance of the instrument to be used 
throughout the period of stability testing 
STABILITY TESTING 
METHODS 
Accelerated stability testing 
• In accelerated stability testing, a product is stressed at several 
high (warmer than ambient) temperatures and the amount of 
heat input required to cause product failure is determined. 
•  This is done to subject the product to a condition that 
accelerates degradation.  
• This information is then projected to predict shelf life or used 
to compare the relative stability of alternative formulations. 
• This usually provides an early indication of the product shelf 
life and thus shortening the development schedule.  
• In addition to temperature, stress conditions applied during 
accelerated stability testing are moisture, light, agitation, 
gravity, pH and package 
STABILITY TESTING 
METHODS 
Accelerated stability testing 
• In accelerated stability testing the samples are subjected to stress, 
refrigerated after stressing, and then assayed simultaneously. 
•  Because the duration of the analysis is short, the likelihood of 
instability in the measurement system is reduced in comparison to the 
real-time stability testing.  
• Further, in accelerated stability testing, comparison of the unstressed 
product with stressed material is made within the same assay and the 
stressed sample recovery is expressed as percent of unstressed sample 
recovery.  
• For statistical reasons, the treatment in accelerated stability 
projections is recommended to be conducted at four different stress 
temperatures.  
• However, for thermolabile and proteinaceous components, relatively 
accurate stability projections are obtained when denaturing stress 
temperatures are avoided 
STABILITY TESTING 
METHODS 
Accelerated stability testing 
• The concept of accelerated stability testing is based upon the Arrhenius equation  




 K = degradation rate/s,  
A = frequency factor/s, (Specifically relates to molecular collision, deals with the frequency of 
molecules that collide in the correct orientation and with enough energy to initiate a reaction. 
It is a factor that is determined experimentally, as it varies with different reactions) 
ΔE = activation energy (kJ/mol),  
R = universal gas constant (0.00831kJ/mol),  
T=absolute temperature (K) 
This equation describe the relationship between storage temperatures and degradation rate.  
Using Arrhenius equation, projection of stability from the degradation rates observed at high 
temperatures for some degradation processes can be determined. 
• When the activation energy is known, the degradation rate at low temperatures may be 
projected from those observed at “stress” temperatures 
• The stress tests used in the current International Conference on Harmonization (ICH) 
guideline (e.g., 40% for products to be stored at controlled room temperature) were 
developed from a model that assumes energy of activation of about 83 kJ per mole 
STABILITY TESTING 
METHODS 
• It explains the effect of temperature on rate of a reaction. 
According to Arrhenius, for every 10º rise in temperature, the 
speed of reaction increases about 2-3 times 
• Estimation of k value  
• The reaction is conducted at several temperatures.  
•  Concentration of reactants is determined (log(a-x).  
•  Appropriate graphs are drawn for the kinetic data.  
• Data is processed for all the orders.  
• The order of the reaction is identified.  




tg α = - k / 2,303 
K = - 2,303 tg α 
STABILITY TESTING 
METHODS 
By using Arrhenius relationship, Log k values are plotted against 
reciprocal of absolute temperature 
Extrapolate the straight line to room temperature (k25) and read the 




• With substitution of the k26 value in the equation, the shelf life 






• Shelf life is defined as the time necessary for the drug to decay 











Retained sample stability testing 
• This is a usual practice for every marketed product for which 
stability data are required. In this study, stability samples, for 
retained storage for at least one batch a year are selected.  
• If the number of batches marketed exceeds 50, stability 
samples from two batches are recommended to be taken. At the 
time of first introduction of the product in the market, the 
stability samples of every batch may be taken, which may be 
decreased to only 2% to 5% of marketed batches at a later 
stage. 
•  In this study, the stability samples are tested at predetermined 
intervals i.e. if a product has shelf life of 5 years, it is 
conventional to test samples at 3, 6, 9, 12, 18, 24, 36, 48, and 
60 months. 
•  This conventional method of obtaining stability data on 
retained storage samples is known as constant interval method 
STABILITY TESTING 
METHODS 
Retained sample stability testing 
• Stability testing by evaluation of market samples is a 
modified method which involves taking samples already 
in the market place and evaluating stability attributes.  
• This type of testing is inherently more realistic since it 
challenges the product not just in the idealized retained 




• Cyclic temperature stress testing 
• This is not a routine testing method for marketed products. In 
this method, cyclic temperature stress tests are designed on 
knowledge of the product so as to mimic likely conditions in 
market place storage. 
•  The period of cycle mostly considered is 24 hours since the 
diurnal rhythm on earth is 24 hours, which the marketed 
pharmaceuticals are most likely to experience during storage.  
• The minimum and maximum temperatures for the cyclic stress 
testing is recommended to be selected on a product by- product 
basis and considering factors like recommended storage 
temperatures for the product and specific chemical and 
physical degradation properties of the products. It is also 
recommended that the test should normally have 20 cycles 
EXPIRATION 
DATE/SHELF LIFE 
• An expiration date is defined as the time up to which the 
product will remain stable when stored under recommended 
storage conditions. Thus, an expiration date is the date beyond 
which it is predicted that the product may no longer retain 
fitness for use.  
• If the product is not stored in accordance with the 
manufacturer’s instructions, then the product may be expected 
to degrade more rapidly.  
• Shelf life is the time during which the product, if stored 
appropriately as per the manufacturer’s instructions, will retain 
fitness for use (>90% of label claim of potency). 
• The expiration date is also defined as the date placed on the 
container/labels of a drug product designating the time during 
which a batch of the product is expected to remain within the 
approved shelf life specifications, if stored under defined 





• Estimation of Shelf Life 
• The shelf life is determined from the data obtained from the 
long term storage studies. The data is first linearized and test 
for goodness of fit is applied. The linearized data is then 
analyzed to see that the slope and the intercepts are matching.  
• For determination of significance of difference in case of slope 
or intercept, statistical tests like t-test should be applied. The 
data is available in the form of only five data points i.e. 0, 3, 6, 
9 and 12 months, either pooled from the three batches or from 
the three individual batches if they are not fit for pooling. In 
case data is not fit for pooling, stability estimates are to be 
made on the worst batch. The shelf life/expiry date is 
determined from the regression line of this five point data 
based on calculation of 95% one-sided confidence limit. 
EXPIRATION 
DATE/SHELF LIFE 
• Estimation of Shelf Life 
• For reading the expiry date, 90% drug concentration is 
considered as the lowest specification limit and the point 
where the extension line cuts the 95% confidence limit 
line is taken as an expiry date.  
• For new drugs, it is a general practice to grant only two-
year expiry initially, which is based on satisfactory one 
year long-term and 6 months accelerated stability data.  
• The expiry date for third and later years is allowed only 
on production of real-time data for the subsequent years 
EXPIRATION 
DATE/SHELF LIFE 
• Estimation of Shelf Life 
• Most pharmaceutical products are characterized by only 
one shelf life. However, in some cases a product may 
have two e.g. a freeze-dried (lyophilized) protein product 
may have only 1 shelf life, say 2 years, for the product 
stored in the dry condition and a 2nd shelf life, say 2 days, 
for the product when it has been reconstituted with the 
appropriate vehicle and is ready for injection. 
PROTOCOL FOR 
STABILITY TESTING 
• The protocol for stability testing is a pre-requisite for starting 
stability testing and is necessarily a written document that 
describes the key components of a regulated and well-
controlled stability study.  
• Because the testing condition is based on inherent stability of 
the compound, the type of dosage form and the proposed 
container-closure system, the protocol depends on the type of 
drug substance or the product.  
• In addition, the protocol can depend on whether the drug is 
new or is already in the market 
• The protocol should also reflect the regions where the product 
is proposed to be marketed e.g. if the product is planned to be 
used in climatic zones I-III, IVa and IVb, the stability program 
must include all these zones 
PROTOCOL FOR 
STABILITY TESTING 
• A well designed stability protocol should contain the following 
information: 
• 1. BATCHES 
• Stability studies at developmental stages are generally carried out on 
a single batch while studies intended for registration of new product 
or unstable established product are done on first three production 
batches, while for stable and well-established batches, even two are 
allowed.  
• If the initial data is not on a fullscale production batch, first three 
batches of drug product manufactured post-approval should be placed 
on long-term studies using the same protocol as in approved drug 
application.  
• Data on laboratory scale batches obtained during development of 
pharmaceuticals are not accepted as primary stability data but 
constitute supportive information.  
• In general, the selection of batches should constitute a random 
sample from the population of pilot or production batches 
PROTOCOL FOR 
STABILITY TESTING 
• Containers and closures 
• The testing is done on the product in immediate containers and 
closures proposed for marketing.  
• The packaging materials include aluminum strip packs, blister packs, 
Alu-Alu packs, HDPE bottles etc. This may also include secondary 
packs, but not shippers.  
• Products in all different types of containers/closures, whether meant 
for distribution or for physician and promotional samples, are to be 
tested separately.  
• However, for bulk containers, testing in prototype containers is 
allowed, if it simulates the actual packaging 
PROTOCOL FOR 
STABILITY TESTING 
• Orientation of storage of containers 
• Samples of the solutions, dispersed systems and semi solid drug 
products for stability studies must be kept upright and positioned 
either inverted or on the side to allow for full interaction of the 
product with the container-closure.  
• This orientation helps to determine whether the contact between the 
drug product or solvent and the closure results in the extraction of 
chemical substances from the closure components or adsorption of 
product components in to the container-closure. 
PROTOCOL FOR 
STABILITY TESTING 
Sampling time points 
• Frequency of testing should be such that it is sufficient to establish 
the stability profile of the new drug substance. For products with a 
proposed shelf life of at least 12 months, the testing frequency at the 
long-term storage condition should be every 3 months over the first 
year, every 6 months over the second year and annually thereafter 
throughout the proposed shelf life expiration date. In the case of 
accelerated storage conditions, a minimum of three time points, 
including the initial and end points, for example, 0, 3, and 6 months 
is recommended. 
•  When testing at the intermediate storage condition is necessary as a 
result of significant change at the accelerated storage condition, a 
minimum of four test points, including the initial and final time 




• Sampling plan for stability testing involves, planning for the number of samples to be 
charged to the stability chambers and sampling out of the charged batch so as to cover 
the entire study. 
• The first step should be the development of the sampling time points followed by the 
number of samples needed to be drawn at each pull point for complete evaluation of 
all test parameters and finally adding up to get the total number of samples. For 
example there would be a requirement of about 100 tablets per pull out in a long term 
or accelerated stability studies including 10 each for assay, hardness and moisture 
determination, 6 each for dissolution and disintegration and 50 for friability.  
• This multiplied by the total number of pull outs will give the total number of tablets 
required for a study. This is followed by the development of a sampling plan, which 
includes the selection of the containers representing the batch as a whole but in an 
unbiased manner. A stratification plan has been suggested whereby from a random 
starting point every nth container is taken from the filling or packaging line (n is 




• The stability test protocol should define the test parameters that 
would be used for evaluation of the stability samples. The tests that 
monitor the quality, purity, potency, and identity which could be 
expected to change upon storage are chosen as stability tests. 
•  Therefore appearance, assay, degradation products, microbiological 
testing, dissolution, and moisture are standard tests performed on 
stability test samples.  
• Microbiological tests include sterility, preservative efficacy and 
microbial count as applicable e.g. for liquid injectable preparations. 
•  The batches used for stability study must meet all the testing 
requirements including heavy metals, residue on ignition, residual 
solvents etc. Some of these are required at the time of product release 
but not required to be repeated during stability testing 
STABILITY TEST 
EQUIPMENT 
• The equipment used for stability testing is called stability chamber. These are 
specialized environmental chambers that can simulate the storage condition and enable 
evaluation of product stability based on real-time, accelerated and long-term protocols. 
• They are available in both walk-in and reach-in styles. Smaller chambers are preferred 
for accelerated testing, as the retention time of products is much less in these cabinets, 
while the walk-in chambers are preferred for long-term testing. 
STABILITY TEST 
EQUIPMENT 
• Such chambers or rooms are engineered and qualified to 
ensure uniform exposure of the set conditions to all the 
samples in the chamber. These chambers are expected to be 
dependable and rugged because of the requirement of 
uninterrupted use for years.  
• They are fitted with appropriate recording, safety and alarm 
devices. In addition, photostability chambers are also available 
and utilized both with and without temperature and humidity 
control. 
• Two types of light sources are usually employed in 
photostability chambers, one is the combination of cool white 
and near UV fluorescent tubes, while second are the artificial 
daylight lamps, e.g., xenon or metal halide. 
• The visible light intensity is estimated using a lux meter. The 
calculation is made on how many hours of exposure is needed 
